Evidence map›Paper›PMID 31578253›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Mapping low-affinity/high-specificity peptide-protein interactions using ligand-footprinting mass spectrometry.

Benjamin W Parker, Edward J Goncz, David T Krist, Alexander V Statsyuk, Alexey I Nesvizhskii, Eric L Weiss

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. LiF-MS+, a revised technique for mapping peptide-protein interactions.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Towards rational computational peptide design.Frontiers in bioinformatics · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Benjamin W ParkerDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208.
Edward J GonczDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208.
David T KristChemistry of Life Processes Institute, Department of Chemistry, Northwestern University, Evanston, IL 60208.
Alexander V StatsyukChemistry of Life Processes Institute, Department of Chemistry, Northwestern University, Evanston, IL 60208.
Alexey I NesvizhskiiDepartment of Pathology, University of Michigan, Ann Arbor, MI 48109.
Eric L WeissDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208; elweiss@northwestern.edu.
Northwestern University · USUniversity of Michigan–Ann Arbor · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
University of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1M
Control and function of the yeast RAM networkR01GM084223 · NIGMS · NORTHWESTERN UNIVERSITY · PI WEISS, ERIC LYLE · 2008 to 2017
$2.9M
NCI NIH HHS P30 CA060553NCI NIH HHS U24 CA210967NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R01 GM084223NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

Short linear peptide motifs that are intracellular ligands of folded proteins are a modular, incompletely understood molecular interaction language in signaling systems. Such motifs, which frequently occur in intrinsically disordered protein regions, often bind partner proteins with modest affinity and are difficult to study with conventional structural biology methods. We developed LiF-MS (ligand-footprinting mass spectrometry), a method to map peptide binding sites on folded protein domains that allows consideration of their dynamic disorder, and used it to analyze a set of D-motif peptide-mitogen-activated protein kinase (MAPK) associations to validate the approach and define unknown binding structures. LiF-MS peptide ligands carry a short-lived, indiscriminately reactive cleavable crosslinker that marks contacts close to ligand binding sites with high specificity. Each marked amino acid provides an independent constraint for a set of directed peptide-protein docking simulations, which are analyzed by agglomerative hierarchical clustering. We found that LiF-MS provides accurate ab initio identification of ligand binding surfaces and a view of potential binding ensembles of a set of D-motif peptide-MAPK associations. Our analysis provides an MKK4-JNK1 structural model, which has thus far been crystallographically unattainable, a potential alternate binding mode for part of the NFAT4-JNK interaction, and evidence of bidirectional association of MKK4 peptide with ERK2. Overall, we find that LiF-MS is an effective noncrystallographic way to understand how short linear motifs associate with specific sites on folded protein domains at the level of individual amino acids.

Indexed as

Amino Acid MotifsBinding SitesHumansLigandsMAP Kinase Signaling SystemMass SpectrometryMitogen-Activated Protein KinasesPeptidesProtein BindingProtein FoldingProtein Interaction MappingLigandsMitogen-Activated Protein KinasesPeptidesdisordered proteindocking interactionsMAP kinasesmass spectrometrypeptide ligands

Identifiers

PMID31578253
PMCPMC6800362
OpenAlexW2977985305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.